Importantly, our target prediction approach did not incorporate data from RSV-infected cells, thus further supporting the notion that the predicted targets also work beyond the three viruses initially included in our analysis
Similarly, Wegovy, initially known for its weight loss effects, was approved in August 2025 for the treatment of metabolic dysfunction-associated steatohepatitis (MASH)
Pirfenidone: Molecular mechanisms and potential clinical applications in lung disease
I want to see what's happening inside the tendon or fascia, not just map where it hurts
Curr Opin Endocrinol Diabetes Obes 17:446452
"And I might either want my money back or I want a replacement for what I have." Another Zappy patient, Nicole Drong, in Minneapolis, says she was surprised when vials marked "Ousia" arrived at her home